Type1diabetesNCT07380802
Petit Cactus Study
A study testing Petit Cactus in people with Type1diabetes, run by McGill University at 1 site in Canada.
Trial summary
The goal of this trial is to test a newly developed carbohydrate counting mobile application (named Petit Cactus) with photo recognition, for people with type 1 diabetes. To evaluate Petit Cactus, our objectives are: 1. Read more about this study
- Who is it for?
- Ages 14 years and older
- Conditions the study is for
- Type1diabetes
- What is being tested?
- Petit Cactus
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 73 participants
- Where
- 1 siteCanada
- Study dates
- 20 Feb 2025to 30 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Diagnosed with T1D for at least 1 year on basal-bolus insulin regimen
- Uses a Continuous Glucose Monitoring (CGM) system
- Aged 14 years or older; 4. Residing in Canada
- Able to speak/understand French or English
- Uses carbohydrate counting as part of treatment regimen i.e., knows their insulin-to-carb ratio and correction factors.
Who cannot join
- Unable to use a smartphone with internet access
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Petit Cactus: A Carbohydrate Counting Mobile Application for Canadians With Type 1 Diabetes - A Proof-of-Concept Study
The goal of this trial is to test a newly developed carbohydrate counting mobile application (named Petit Cactus) with photo recognition, for people with type 1 diabetes. To evaluate Petit Cactus, our objectives are: 1. To measure the association between app engagement and changes in blood glucose management over the same period. 2. To assess the usability of the app, focusing on engagement (i.e., frequency of meal logs) over 3 months and user satisfaction. 3. To validate the nutritional data obtained from the app's photo recognition algorithm by comparing it with a validated nutrient intake method (in this case, a web-based 24h recall).
Participants will submit their Ambulatory Glucose Profile (i.e., CGM data) at the beginning and at the end of 3 months, download the app to use for carbohydrate counting for the 3-month duration, complete a usability questionnaire at the end of 3 months, and complete an end-of-study interview to report on their satisfaction with the app.
Read the detailed description
Design and description of methodology: A decentralized mixed-method proof of concept using a pre-post design.
- Enrolment in the study: 1.1. Convenience sampling of 73 participants (aged 14 years and older) to use the Petit Cactus app for 3 months. 1.2. The link to the study will be distributed via Limesurvey to participants of the Canadian T1D BETTER registry as well as through social media and diabetes organization. 1.3. Upon reviewing the study objectives, procedures, and details of their participation on the link, potential participants will confirm eligibility, before being able to proceed with the electronic informed consent. 1.4. An invitation to sign their name, along with a clear explanation, stating that signing their name electronically is equal to a written signature, and is required to express consent. 1.5. Participants will be asked for their preferred method of communication, phone number or email, to be contacted by research personnel to schedule a call to confirm eligibility, review study methodology, and confirm enrolment in the study.
- Demographic and diabetes management intake questionnaire: After completing the e-consent process and providing informed consent, participants will be invited to complete a demographic and diabetes management questionnaire on LimeSurvey. 2.1.1. Demographic variables: Age, self-identified gender, ethnicity, country of birth, highest level of education, work status, annual household income. 2.1.2. Diabetes management: Duration since diagnosis, method of insulin administration (multiple daily injections, insulin pumps, use of Automated Insulin Delivery; AID), type of CGM, A1c in the last 3 months (reported; continuous variable), reported number of serious (less than 3 mmol/L) and severe hypoglycemic (i.e., requiring external help) events in the last month. 2.1.3. Carbohydrate counting methods: a. Frequency of carb counting (at every meal and snack, at least once a day, at least once per week, less than once a week) b. Approximate duration of carbohydrate counting (in years; continuous variable) c. Use of apps to assist with carb counting (Yes/No) d. Reported perceived ability to perform CC: "I feel confident in my ability to determine the insulin dose given at mealtime based on the quantity of carbohydrates in my meals and/or snacks using an insulin-to-carb ratio" (Likert scale: Strongly disagree = 1; Strongly agree = 5). 2.1.4. Blood glucose management from CGM data (T=0): Estimated A1c, time-in-range, and hypoglycemic events at baseline. Participants will be invited to send us, through a personalized link to a One drive folder, their most recent Ambulatory Glucose Profile (AGP) report, which is an analysis generated using the last 14 days of glucose changes, accessible on their CGM device portal, to complete enrolment in the study.
- Access to the mobile application: Petit Cactus for 3 months: participants will be enrolled in the study by receiving, through email: a. Link to download the app on their phone; from the App store if using an iPhone or Play store if using an Android phone device. b. Petit Cactus user guide PDF developed by our research team for research purposes. c. During the account creation process on the app, users will be informed that all identifiable data from the submitted demographic and diabetes management intake forms are kept confidential by the research team. Hence, participants have the option to refrain from disclosing information on age, date of birth, and gender in their profile settings at their own discretion. Pseudonyms can be used instead of real names if preferred.
- Data collection on engagement throughout the trial duration The usability of the app will be assessed over 3 months through engagement with Petit Cactus, i.e., the frequency of meal logs in the app, using mobile app metrics (Google Analytics).
- Completion of five (5) 24h recall using the validated R24W during the trial duration: To validate the app-based photo recognition algorithm, nutritional data (namely carbohydrates count) will be collected at 5 random days between T=0 and three-month T=3, to account for day-to-day variability in dietary intake. The days will encompass different contexts (weekday versus weekend). The data will be compared between a validated tool for nutritional intake and assessment, namely the R24W, and Petit Cactus. While participants complete the 24h recall on the R24W platform, their access to the app will be blocked until submission of the questionnaire. If participants do not complete the 24-hour recall within the allocated time, their access will be restored to the app, and the link to the R24W will expire. Participants will be contacted by phone or email to inquire on the reason for not completing the 24h recall and inform them that another invitation to the R24W platform will be sent out (the day will not be announced). A maximum of 6 invitations, where applicable, will be sent out to aim for 5 days of data collection. This process will be explained to the participants beforehand. To complete the R24W, participants will have to: 4.5.1.1. Click on the personalized link received by email at midnight to complete a 24-hour recall. Participants will have until midnight the following day to complete the questionnaire on their food and drink intake. No logins are required; answers are saved in real-time, and the questionnaire can be completed in multiple sessions, provided it's done before the end of the day. 4.5.1.2. Watch the mandatory 5-min tutorial on how to complete the 24h recall. 4.5.1.3. Answer the following: Date of birth, Sex at birth, Are you pregnant? Are you breastfeeding? Such information is important to contextualize the food intake. 4.5.1.4. Confirm the day for recalling their food and drink intake, e.g.: "You will need to indicate all the food and drinks you consumed on Thursday, April 25th, between midnight and midnight." 4.5.1.5. Complete the questionnaire by entering all meals consumed during the day: Type of meal, time of meal, context of meal i.e., location, alone/with company, screen time, manual food selection from database, portion size selection using visual cues, verification of meal entry, and supplementary intake: any food that could not be entered in the questionnaire, water intake, representativeness of everyday eating habits, other supplements taken in addition to food intake. 4.5.1.6. Confirm the reported intake and submit questionnaire. 4.5.1.7. Repeat for 4 other days.
- Completion of an online satisfaction questionnaire with Petit Cactus At 3 months (end of the study), all participants will receive an online System Usability Scale (SUS) online questionnaire via email to gather quantitative feedback on their satisfaction with the app. In addition to the questionnaire, there will be an additional question on the reported perceived ability to perform CC: "I feel confident in my ability to determine the insulin dose given at mealtime based on the quantity of carbohydrates in my meals and/or snacks using an insulin-to-carb ratio" rated on a Likert scale from Strongly disagree (1) to Strongly agree (5).
- Invitation to semi-structured individual interviews: After completing the online satisfaction questionnaire, a subset, randomly selected participants (20-28), will be invited to participate in individual interviews. Questions were derived from the SUS questionnaire to explore responses more deeply and facilitate triangulation of the results.
- Blood glucose management from CGM data (T=3) To compare pre- and post-CGM data (i.e., estimated A1c, time-in-range, and hypoglycemic events) participants will be, once again, invited to send us their most recent Ambulatory Glucose Profile (AGP) report by email or download it directly into a personalized link to a One drive folder at the end of the trial (T=3).
- Conditions
- Type1diabetes
- Being tested
- Petit Cactus
- Keywords
- Type1diabetes, Carbohydrate Counting, Usability, Glycemic Management, Mobile Application
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Petit CactusDevice
Access to the mobile application named Petit Cactus for 3 months to assist with carbohydrate counting in the context of type 1 diabetes using the following features: 1) Identify and log food items and estimate quantities through both photo recognition and manual selection from canadian food databases, 2) Automatically calculate and suggest the bolus insulin dose needed for a meal, based on the insulin-to-carbohydrate ratios entered in the settings and previously determined by the endocrinologist and healthcare team. 3) Track meals and different logged events (physical activity, stress levels, menstrual cycle...) and their impact on blood glucose levels.
| Study group | Role | What they receive |
|---|---|---|
| Petit Cactus | Experimental | Access to "Petit Cactus" carbohydrate counting app to assist with meal logs for 3 months Receives: Device: Petit Cactus |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time-in-Range
Percentage of the time that glucose levels were within the recommended range (3.9 mmol/L and 10 mmol/L)
Measured: At baseline and 3 months
Estimated A1c
Estimated glucose levels i.e., glucose management indicator (GMI)
Measured: At baseline and at 3 months
Engagement
the frequency of meal logs in the app
Measured: Throughout the 3 months
System Usability System Scale
System usability system (SUS) scale / 10 items) to assess how usable a system (the app) is, the higher the score (out of 100) the higher the usability.
Measured: At 3 months
Usability perception and experiences themes
Thematic analysis of semi-structured interviews using an interview guide entered around the 10 items of the system usability scale
Measured: At 3 months
Secondary outcomes (1)
Petit Cactus' nutrient analysis validation
The carbohydrate counts from logged meals generated using similar Canadian food databases in both the Petit Cactus app and the validated web-based 24-hour recall (R24W) platform will be compared.
Measured: Five random days from baseline until the end of the 3-month trial
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Feb 2026
- Study start20 Feb 2025
- Primary completion15 Aug 2025
- Study completion30 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Type1diabetesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Decentralized mixed-methods quasi-experimental trial with pre-post design
- Masking
- None (open label)
- Enrolment
- 73 participants (actual)
Sponsor and investigators
- Lead sponsor
- McGill University
- Sponsor type
- University, hospital or other
- Collaborators
- Laval University
- Responsible party
- Principal investigator, Anne-Sophie Brazeau, McGill University
- Investigators
- Anne-Sophie Brazeau, PhD, Principal investigator, McGill University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07380802
- Sponsor's protocol ID
- 24-05-011
- Status last verified
- Jan 2026
- First submitted
- 22 Sep 2025
- Last updated
- 2 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: IPD will not be shared due to ethical considerations and the lack of participant consent for data sharing beyond the current study.
Publications
Housni A, Katz A, Bergeron LJ, Simard A, Finkel A, Roy-Fleming A, Nakhla M, Brazeau AS. Bridging the Gap in Carbohydrate Counting With a Mobile App: Needs Assessment Survey. J Med Internet Res. 2025 Mar 28;27:e63278. doi: 10.2196/63278.
PubMed 40153793Laramee C, Lemieux S, Robitaille J, Lamarche B. Comparing the Usability of the Web-Based 24-h Dietary Recall R24W and ASA24-Canada-2018 among French-Speaking Adults from Quebec. Nutrients. 2022 Oct 28;14(21):4543. doi: 10.3390/nu14214543.
PubMed 36364803Fu S, Li L, Deng S, Zan L, Liu Z. Effectiveness of advanced carbohydrate counting in type 1 diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2016 Nov 14;6:37067. doi: 10.1038/srep37067.
PubMed 27841330Fortin A, Rabasa-Lhoret R, Roy-Fleming A, Desjardins K, Brazeau AS, Ladouceur M, Gingras V. Practices, perceptions and expectations for carbohydrate counting in patients with type 1 diabetes - Results from an online survey. Diabetes Res Clin Pract. 2017 Apr;126:214-221. doi: 10.1016/j.diabres.2017.02.022. Epub 2017 Feb 22.
PubMed 28273644Ziegler R, Rees C, Jacobs N, Parkin CG, Lyden MR, Petersen B, Wagner RS. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy: results of the Bolus Advisor Benefit Evaluation (BABE) study. Pediatr Diabetes. 2016 Aug;17(5):311-8. doi: 10.1111/pedi.12290. Epub 2015 Jun 15.
PubMed 26073672Tascini G, Berioli MG, Cerquiglini L, Santi E, Mancini G, Rogari F, Toni G, Esposito S. Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes. Nutrients. 2018 Jan 22;10(1):109. doi: 10.3390/nu10010109.
PubMed 29361766
Study at a glance
From the registry record, last updated by the sponsor on 2 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Petit Cactus: A Carbohydrate Counting Mobile Application for Canadians With Type 1 Diabetes - A Proof-of-Concept Study
- ClinicalTrials.gov ID
- NCT07380802
- Acronym / sponsor ID
- 24-05-011
- Conditions
- Type1diabetes
- Keywords
- Type1diabetes, Carbohydrate Counting, Usability, Glycemic Management, Mobile Application
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 73 participants (actual)
- Lead sponsor
- McGill UniversityUniversity, hospital or other
- Collaborators
- Laval University
- Study start
- 20 Feb 2025 (actual)
- Primary completion
- 15 Aug 2025 (actual)
- Study completion
- 30 Aug 2025 (actual)
- First posted
- 2 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this trial is to test a newly developed carbohydrate counting mobile application (named Petit Cactus) with photo recognition, for people with type 1 diabetes. To evaluate Petit Cactus, our objectives are: 1. To measure the association between app engagement and changes in blood glucose management over the same period. 2. To assess the usability of the app, focusing on engagement (i.e., frequency of meal logs) over 3 months and user satisfaction. 3. To validate the nutritional data obtained from the app's photo recognition algorithm by comparing it with a validated nutrient intake method (in this case, a web-based 24h recall).
Participants will submit their Ambulatory Glucose Profile (i.e., CGM data) at the beginning and at the end of 3 months, download the app to use for carbohydrate counting for the 3-month duration, complete a usability questionnaire at the end of 3 months, and complete an end-of-study interview to report on their satisfaction with the app.
Detailed description
Design and description of methodology: A decentralized mixed-method proof of concept using a pre-post design.
- Enrolment in the study: 1.1. Convenience sampling of 73 participants (aged 14 years and older) to use the Petit Cactus app for 3 months. 1.2. The link to the study will be distributed via Limesurvey to participants of the Canadian T1D BETTER registry as well as through social media and diabetes organization. 1.3. Upon reviewing the study objectives, procedures, and details of their participation on the link, potential participants will confirm eligibility, before being able to proceed with the electronic informed consent. 1.4. An invitation to sign their name, along with a clear explanation, stating that signing their name electronically is equal to a written signature, and is required to express consent. 1.5. Participants will be asked for their preferred method of communication, phone number or email, to be contacted by research personnel to schedule a call to confirm eligibility, review study methodology, and confirm enrolment in the study.
- Demographic and diabetes management intake questionnaire: After completing the e-consent process and providing informed consent, participants will be invited to complete a demographic and diabetes management questionnaire on LimeSurvey. 2.1.1. Demographic variables: Age, self-identified gender, ethnicity, country of birth, highest level of education, work status, annual household income. 2.1.2. Diabetes management: Duration since diagnosis, method of insulin administration (multiple daily injections, insulin pumps, use of Automated Insulin Delivery; AID), type of CGM, A1c in the last 3 months (reported; continuous variable), reported number of serious (less than 3 mmol/L) and severe hypoglycemic (i.e., requiring external help) events in the last month. 2.1.3. Carbohydrate counting methods: a. Frequency of carb counting (at every meal and snack, at least once a day, at least once per week, less than once a week) b. Approximate duration of carbohydrate counting (in years; continuous variable) c. Use of apps to assist with carb counting (Yes/No) d. Reported perceived ability to perform CC: "I feel confident in my ability to determine the insulin dose given at mealtime based on the quantity of carbohydrates in my meals and/or snacks using an insulin-to-carb ratio" (Likert scale: Strongly disagree = 1; Strongly agree = 5). 2.1.4. Blood glucose management from CGM data (T=0): Estimated A1c, time-in-range, and hypoglycemic events at baseline. Participants will be invited to send us, through a personalized link to a One drive folder, their most recent Ambulatory Glucose Profile (AGP) report, which is an analysis generated using the last 14 days of glucose changes, accessible on their CGM device portal, to complete enrolment in the study.
- Access to the mobile application: Petit Cactus for 3 months: participants will be enrolled in the study by receiving, through email: a. Link to download the app on their phone; from the App store if using an iPhone or Play store if using an Android phone device. b. Petit Cactus user guide PDF developed by our research team for research purposes. c. During the account creation process on the app, users will be informed that all identifiable data from the submitted demographic and diabetes management intake forms are kept confidential by the research team. Hence, participants have the option to refrain from disclosing information on age, date of birth, and gender in their profile settings at their own discretion. Pseudonyms can be used instead of real names if preferred.
- Data collection on engagement throughout the trial duration The usability of the app will be assessed over 3 months through engagement with Petit Cactus, i.e., the frequency of meal logs in the app, using mobile app metrics (Google Analytics).
- Completion of five (5) 24h recall using the validated R24W during the trial duration: To validate the app-based photo recognition algorithm, nutritional data (namely carbohydrates count) will be collected at 5 random days between T=0 and three-month T=3, to account for day-to-day variability in dietary intake. The days will encompass different contexts (weekday versus weekend). The data will be compared between a validated tool for nutritional intake and assessment, namely the R24W, and Petit Cactus. While participants complete the 24h recall on the R24W platform, their access to the app will be blocked until submission of the questionnaire. If participants do not complete the 24-hour recall within the allocated time, their access will be restored to the app, and the link to the R24W will expire. Participants will be contacted by phone or email to inquire on the reason for not completing the 24h recall and inform them that another invitation to the R24W platform will be sent out (the day will not be announced). A maximum of 6 invitations, where applicable, will be sent out to aim for 5 days of data collection. This process will be explained to the participants beforehand. To complete the R24W, participants will have to: 4.5.1.1. Click on the personalized link received by email at midnight to complete a 24-hour recall. Participants will have until midnight the following day to complete the questionnaire on their food and drink intake. No logins are required; answers are saved in real-time, and the questionnaire can be completed in multiple sessions, provided it's done before the end of the day. 4.5.1.2. Watch the mandatory 5-min tutorial on how to complete the 24h recall. 4.5.1.3. Answer the following: Date of birth, Sex at birth, Are you pregnant? Are you breastfeeding? Such information is important to contextualize the food intake. 4.5.1.4. Confirm the day for recalling their food and drink intake, e.g.: "You will need to indicate all the food and drinks you consumed on Thursday, April 25th, between midnight and midnight." 4.5.1.5. Complete the questionnaire by entering all meals consumed during the day: Type of meal, time of meal, context of meal i.e., location, alone/with company, screen time, manual food selection from database, portion size selection using visual cues, verification of meal entry, and supplementary intake: any food that could not be entered in the questionnaire, water intake, representativeness of everyday eating habits, other supplements taken in addition to food intake. 4.5.1.6. Confirm the reported intake and submit questionnaire. 4.5.1.7. Repeat for 4 other days.
- Completion of an online satisfaction questionnaire with Petit Cactus At 3 months (end of the study), all participants will receive an online System Usability Scale (SUS) online questionnaire via email to gather quantitative feedback on their satisfaction with the app. In addition to the questionnaire, there will be an additional question on the reported perceived ability to perform CC: "I feel confident in my ability to determine the insulin dose given at mealtime based on the quantity of carbohydrates in my meals and/or snacks using an insulin-to-carb ratio" rated on a Likert scale from Strongly disagree (1) to Strongly agree (5).
- Invitation to semi-structured individual interviews: After completing the online satisfaction questionnaire, a subset, randomly selected participants (20-28), will be invited to participate in individual interviews. Questions were derived from the SUS questionnaire to explore responses more deeply and facilitate triangulation of the results.
- Blood glucose management from CGM data (T=3) To compare pre- and post-CGM data (i.e., estimated A1c, time-in-range, and hypoglycemic events) participants will be, once again, invited to send us their most recent Ambulatory Glucose Profile (AGP) report by email or download it directly into a personalized link to a One drive folder at the end of the trial (T=3).
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Decentralized mixed-methods quasi-experimental trial with pre-post design
| Arm | Type | Receives |
|---|---|---|
| Petit Cactus | Experimental | Device: Petit CactusAccess to "Petit Cactus" carbohydrate counting app to assist with meal logs for 3 months |
Who may qualify
- Ages
- 14 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Diagnosed with T1D for at least 1 year on basal-bolus insulin regimen
- Uses a Continuous Glucose Monitoring (CGM) system
- Aged 14 years or older; 4. Residing in Canada
- Able to speak/understand French or English
- Uses carbohydrate counting as part of treatment regimen i.e., knows their insulin-to-carb ratio and correction factors.
Key exclusion criteria (1 listed)
- Unable to use a smartphone with internet access
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Petit CactusAccess to the mobile application named Petit Cactus for 3 months to assist with carbohydrate counting in the context of type 1 diabetes using the following features: 1) Identify and log food items and estimate quantities through both photo recognition and manual selection from canadian food databases, 2) Automatically calculate and suggest the bolus insulin dose needed for a meal, based on the insulin-to-carbohydrate ratios entered in the settings and previously determined by the endocrinologist and healthcare team. 3) Track meals and different logged events (physical activity, stress levels, menstrual cycle...) and their impact on blood glucose levels. | Device | Petit Cactus |
Primary outcome
Time-in-Range
Time frame: At baseline and 3 months
Percentage of the time that glucose levels were within the recommended range (3.9 mmol/L and 10 mmol/L)
Estimated A1c
Time frame: At baseline and at 3 months
Estimated glucose levels i.e., glucose management indicator (GMI)
Engagement
Time frame: Throughout the 3 months
the frequency of meal logs in the app
System Usability System Scale
Time frame: At 3 months
System usability system (SUS) scale / 10 items) to assess how usable a system (the app) is, the higher the score (out of 100) the higher the usability.
Usability perception and experiences themes
Time frame: At 3 months
Thematic analysis of semi-structured interviews using an interview guide entered around the 10 items of the system usability scale
1 secondary outcome
Petit Cactus' nutrient analysis validation
Time frame: Five random days from baseline until the end of the 3-month trial
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Feb 2026.
- Results publication: PubMed 40153793Housni A, Katz A, Bergeron LJ, Simard A, Finkel A, Roy-Fleming A, Nakhla M, Brazeau AS. Bridging the Gap in Carbohydrate Counting With a Mobile App: Needs Assessment Survey. J Med Internet Res. 2025 Mar 28;27:e63278. doi: 10.2196/63278.
- Results publication: PubMed 36364803Laramee C, Lemieux S, Robitaille J, Lamarche B. Comparing the Usability of the Web-Based 24-h Dietary Recall R24W and ASA24-Canada-2018 among French-Speaking Adults from Quebec. Nutrients. 2022 Oct 28;14(21):4543. doi: 10.3390/nu14214543.
- Results publication: PubMed 27841330Fu S, Li L, Deng S, Zan L, Liu Z. Effectiveness of advanced carbohydrate counting in type 1 diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2016 Nov 14;6:37067. doi: 10.1038/srep37067.
- Results publication: PubMed 28273644Fortin A, Rabasa-Lhoret R, Roy-Fleming A, Desjardins K, Brazeau AS, Ladouceur M, Gingras V. Practices, perceptions and expectations for carbohydrate counting in patients with type 1 diabetes - Results from an online survey. Diabetes Res Clin Pract. 2017 Apr;126:214-221. doi: 10.1016/j.diabres.2017.02.022. Epub 2017 Feb 22.
- Results publication: PubMed 26073672Ziegler R, Rees C, Jacobs N, Parkin CG, Lyden MR, Petersen B, Wagner RS. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy: results of the Bolus Advisor Benefit Evaluation (BABE) study. Pediatr Diabetes. 2016 Aug;17(5):311-8. doi: 10.1111/pedi.12290. Epub 2015 Jun 15.
- Results publication: PubMed 29361766Tascini G, Berioli MG, Cerquiglini L, Santi E, Mancini G, Rogari F, Toni G, Esposito S. Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes. Nutrients. 2018 Jan 22;10(1):109. doi: 10.3390/nu10010109.
- Individual participant dataSharing planned: No. IPD will not be shared due to ethical considerations and the lack of participant consent for data sharing beyond the current study.
Related trials for Type1diabetes
Active, not recruitingPhase 4
Diabetes in African Youth
type1diabetes
Recruiting
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Non-Nutritive Sweetener, Type 1 Diabetes
Active, not recruitingPhase 2
Reducing Innate Inflammation in New Onset Type 1 Diabetes
Type 1 Diabetes, type1diabetes
Active, not recruiting
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D - 4T Study
Type1diabetes
Recruiting
Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System
Type1diabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anne-Sophie Brazeau, PhD principal investigator
McGill University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Petit Cactus in people with Type1diabetes, run by McGill University at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time-in-Range (time frame: At baseline and 3 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07380802, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.